| scholarly article | Q13442814 |
| P2093 | author name string | Michael N Starnbach | |
| Cammie F Lesser | |||
| Ngozi A Eze | |||
| Roger W Kramer | |||
| Kara S Giddings | |||
| Keri A Siggers | |||
| Monica F Morrison | |||
| Naomi L Slagowski | |||
| P2860 | cites work | Cell wall assembly in Saccharomyces cerevisiae | Q24549234 |
| An interactional network of genes involved in chitin synthesis in Saccharomyces cerevisiae | Q24800564 | ||
| ShiBASE: an integrated database for comparative genomics of Shigella | Q25257766 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation | Q27933379 | ||
| Global mapping of the yeast genetic interaction network | Q27934987 | ||
| Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile | Q27935813 | ||
| Regulation of the yeast Rlm1 transcription factor by the Mpk1 cell wall integrity MAP kinase. | Q27936197 | ||
| The RIM101 pathway contributes to yeast cell wall assembly and its function becomes essential in the absence of mitogen-activated protein kinase Slt2p | Q27939160 | ||
| Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes | Q28238338 | ||
| Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor | Q28269030 | ||
| CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. | Q28344579 | ||
| Flagellin induces innate immunity in nonhost interactions that is suppressed by Pseudomonas syringae effectors | Q28492432 | ||
| Biochemical and genetic analysis of the yeast proteome with a movable ORF collection | Q29619667 | ||
| The protein kinase C-activated MAP kinase pathway of Saccharomyces cerevisiae mediates a novel aspect of the heat shock response | Q29620800 | ||
| Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways | Q30885679 | ||
| A yeast genetic system for the identification and characterization of substrate proteins transferred into host cells by the Legionella pneumophila Dot/Icm system | Q33214421 | ||
| Type III secretion machines: bacterial devices for protein delivery into host cells | Q33639326 | ||
| GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure | Q33904931 | ||
| Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking | Q33935172 | ||
| Cell wall integrity signaling in Saccharomyces cerevisiae | Q33939988 | ||
| The yeast cell wall and septum as paradigms of cell growth and morphogenesis | Q33942954 | ||
| The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
| Expression of microbial virulence proteins in Saccharomyces cerevisiae models mammalian infection | Q34079370 | ||
| Shigella flexneri Interactions with the Basolateral Membrane Domain of Polarized Model Intestinal Epithelium: Role of Lipopolysaccharide in Cell Invasion and in Activation of the Mitogen-Activated Protein Kinase ERK | Q34120536 | ||
| Control of Bro1-domain protein Rim20 localization by external pH, ESCRT machinery, and the Saccharomyces cerevisiae Rim101 pathway | Q34407330 | ||
| Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation | Q34530978 | ||
| OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence | Q35073836 | ||
| The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. | Q35107685 | ||
| Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection. | Q35411990 | ||
| Modeling the function of bacterial virulence factors in Saccharomyces cerevisiae | Q35859746 | ||
| Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation | Q37007773 | ||
| The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. | Q37861620 | ||
| Characterizing gene sets with FuncAssociate | Q38522379 | ||
| AKR1 encodes a candidate effector of the G beta gamma complex in the Saccharomyces cerevisiae pheromone response pathway and contributes to control of both cell shape and signal transduction | Q40018902 | ||
| Characterization of a serum response factor-like protein in Saccharomyces cerevisiae, Rlm1, which has transcriptional activity regulated by the Mpk1 (Slt2) mitogen-activated protein kinase pathway | Q40022092 | ||
| An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
| Identification of a bacterial type III effector family with G protein mimicry functions. | Q40329601 | ||
| Gene function prediction from congruent synthetic lethal interactions in yeast | Q40510088 | ||
| The SLT2(MPK1) MAP kinase is activated during periods of polarized cell growth in yeast. | Q41063523 | ||
| ShiA abrogates the innate T-cell response to Shigella flexneri infection | Q42079929 | ||
| The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri | Q42638971 | ||
| Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium | Q43982547 | ||
| Shigella effector IpaH9.8 binds to a splicing factor U2AF(35) to modulate host immune responses | Q44053369 | ||
| Modular epistasis in yeast metabolism. | Q51982575 | ||
| A new method for quantitative determination of polysaccharides in the yeast cell wall. Application to the cell wall defective mutants of Saccharomyces cerevisiae | Q77512042 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | affy | Q113334509 |
| P433 | issue | 2 | |
| P921 | main subject | functional genomics | Q1068690 |
| P304 | page(s) | e21 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation | |
| P478 | volume | 3 |
| Q33315560 | A functional genomic yeast screen to identify pathogenic bacterial proteins |
| Q54202312 | A multi-phenotypic imaging screen to identify bacterial effectors by exogenous expression in a HeLa cell line. |
| Q34081736 | A simple yeast-based strategy to identify host cellular processes targeted by bacterial effector proteins |
| Q35228516 | A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation |
| Q39666586 | Anaplasma phagocytophilum AptA modulates Erk1/2 signalling |
| Q34539851 | Approaching the functional annotation of fungal virulence factors using cross-species genetic interaction profiling. |
| Q38105533 | Bacterial subversion of host innate immune pathways |
| Q41411382 | Bacterial virulence proteins as tools to rewire kinase pathways in yeast and immune cells |
| Q41845326 | Combinatorial actions of bacterial effectors revealed by exploiting genetic tools in yeast. |
| Q47546254 | Evolutionary genetics of cytoplasmic incompatibility genes cifA and cifB in prophage WO of Wolbachia. |
| Q40097365 | Expression of HopAI interferes with MAP kinase signalling in Magnaporthe oryzae |
| Q34073801 | Expression of the bacterial type III effector DspA/E in Saccharomyces cerevisiae down-regulates the sphingolipid biosynthetic pathway leading to growth arrest. |
| Q34670249 | Functional annotations for the Saccharomyces cerevisiae genome: the knowns and the known unknowns |
| Q39671943 | Helicobacter pylori CagA inhibits endocytosis of cytotoxin VacA in host cells |
| Q40628816 | Identification and functional characterization of EseH, a new effector of the type III secretion system of Edwardsiella piscicida |
| Q35815841 | Identification of Critical Amino Acids Conferring Lethality in VopK, a Type III Effector Protein of Vibrio cholerae: Lessons from Yeast Model System |
| Q41908165 | Identification of Legionella pneumophila effectors regulated by the LetAS-RsmYZ-CsrA regulatory cascade, many of which modulate vesicular trafficking |
| Q34298317 | Identification of novel Coxiella burnetii Icm/Dot effectors and genetic analysis of their involvement in modulating a mitogen-activated protein kinase pathway |
| Q28472300 | Identification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screen |
| Q90679893 | Identifying Pseudomonas syringae Type III Secreted Effector Function via a Yeast Genomic Screen |
| Q91697488 | LI1035, a putative effector secreted by Lawsonia intracellularis, targets the MAPK pathway and regulates actin organizationin yeast and mammalian cells |
| Q40064811 | Large-Scale Identification of Wolbachia pipientis Effectors |
| Q39915159 | Large-scale identification of Legionella pneumophila Dot/Icm substrates that modulate host cell vesicle trafficking pathways |
| Q33356625 | Legionella eukaryotic-like type IV substrates interfere with organelle trafficking |
| Q35636588 | Manipulation of kinase signaling by bacterial pathogens |
| Q36422508 | Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. |
| Q46271345 | OrfX, a Nucleomodulin Required for Listeria monocytogenes Virulence |
| Q36977518 | Pathogen subversion of cell-intrinsic innate immunity |
| Q50044659 | Pathogenicity of SG 9R, a rough vaccine strain against fowl typhoid |
| Q58610410 | Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner. |
| Q34052892 | Processing and secretion of ROP13: A unique Toxoplasma effector protein |
| Q89533648 | Revealing eukaryotic histone-modifying mechanisms through bacterial infection |
| Q50033878 | Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection |
| Q26771364 | Shigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic Bacteria |
| Q24315859 | Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein |
| Q27649350 | Structural basis for the catalytic mechanism of phosphothreonine lyase |
| Q26773133 | Subverting Toll-Like Receptor Signaling by Bacterial Pathogens |
| Q58613107 | The Antibacterial and Anti-Eukaryotic Type VI Secretion System MIX-Effector Repertoire in |
| Q34612233 | The Shigella type three secretion system effector OspG directly and specifically binds to host ubiquitin for activation |
| Q33782322 | The Vibrio parahaemolyticus Type III Secretion Systems manipulate host cell MAPK for critical steps in pathogenesis |
| Q37214013 | The Yeast Saccharomyces cerevisiae: a versatile model system for the identification and characterization of bacterial virulence proteins |
| Q37375638 | The activities of the Yersinia protein kinase A (YpkA) and outer protein J (YopJ) virulence factors converge on an eIF2alpha kinase |
| Q33582255 | The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. |
| Q28259971 | The versatility of Shigella effectors |
| Q41814223 | Using S. cerevisiae as a Model System to Investigate V. cholerae VopX-Host Cell Protein Interactions and Phenotypes. |
| Q46945422 | Verticillium transcription activator of adhesion Vta2 suppresses microsclerotia formation and is required for systemic infection of plant roots |
| Q36640009 | Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression |
| Q42315430 | VopE, a Vibrio cholerae Type III Effector, Attenuates the Activation of CWI-MAPK Pathway in Yeast Model System |
| Q26766358 | Yeast as a Heterologous Model System to Uncover Type III Effector Function |
Search more.